Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia-Reference-Cited by-同舟云学术

Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia

Published:2013-12 Issue:12 Volume:19 Page:1163-1168
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Holmes N.E.,Turnidge J.D.,Munckhof W.J.,Robinson J.O.,Korman T.M.,O'Sullivan M.V.N.,Anderson T.L.,Roberts S.A.,Warren S.J.C.,Gao W.,Johnson P.D.R.,Howden B.P.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference21 articles.

1. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations;Holmes;J Infect Dis,2011

2. Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet?;Holland;J Infect Dis,2011

3. Outcomes analysis of delayed antibiotic treatment for hospital‐acquired Staphylococcus aureus bacteremia;Lodise;Clin Infect Dis,2003

4. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity;Lesens;Infect Control Hosp Epidemiol,2003

5. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended‐spectrum β‐lactamase production in nosocomial infections;Paterson;Ann Intern Med,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia;Genome Medicine;2018-08-23

2. Genomic Exploration of Within-Host Microevolution Reveals a Distinctive Molecular Signature of PersistentStaphylococcus aureusBacteraemia;2018-02-28

3. Studying new antibiotics for multidrug resistant infections: are today’s patients paying for unproved future benefits?;BMJ;2018-02-22

4. Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis;Clinical Microbiology and Infection;2018-02

5. Reduced Vancomycin Susceptibility of Methicillin-Susceptible Staphylococcus aureus Has No Significant Impact on Mortality but Results in an Increase in Complicated Infection;Antimicrobial Agents and Chemotherapy;2017-07